Publications by authors named "Andrew Lindsley"

Claim this Profile
E
Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
Wojciech Feleszko, Marco Caminati, James E Gern, Sebastian L Johnston, Claudio Marchese, Andrew W Lindsley

Ann Allergy Asthma Immunol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic outcomes in patients with severe asthma and clinically relevant allergy in the CHRONICLE study.
Bradley E Chipps, Warner W Carr, Reynold A Panettieri, Weily Soong, Jennifer Trevor, Andrew W Lindsley

J Allergy Clin Immunol Glob· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, Claire Hopkins, Anju T Peters, Andrew W Lindsley

Int Forum Allergy Rhinol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.
Njira L Lugogo, Praveen Akuthota, Kaharu Sumino, Sameer K Mathur, Autumn F Burnette, Andrew W Lindsley

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tezepelumab in patients with severe, uncontrolled asthma and aspirin-exacerbated respiratory disease in NAVIGATOR.
Tanya M Laidlaw, Kathleen M Buchheit, Katherine N Cahill, Jonathan A Bernstein, Nicole L Martin, Andrew W Lindsley

J Allergy Clin Immunol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.
Njira L Lugogo, Praveen Akuthota, Kaharu Sumino, Sameer K Mathur, Autumn F Burnette, Andrew W Lindsley

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Biologics in Reducing Exacerbations Requiring Hospitalization or an Emergency Department Visit in Patients with Moderate or Severe, Uncontrolled Asthma.
Reynold A Panettieri, Monica Kraft, Mario Castro, Magdalena Bober, Andrew W Lindsley

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps.
Anju Peters, Xiaohui Zhao, Aimee M Near, Joseph Han, Joseph D Spahn, Andrew W Lindsley

Adv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action.
Andrew W Lindsley, Njira Lugogo, Kaitlin A G Reeh, Joseph Spahn, Jane R Parnes

J Asthma Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE).
Melissa M Ross, Yen Chung, Tara Carr, Christopher S Ambrose, Andrew W Lindsley

J Asthma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study.
Dennis K Ledford, Warner W Carr, Wendy C Moore, Njira L Lugogo, Arjun Mohan, Andrew W Lindsley

J Asthma Allergy· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States.
Tara Carr, Joseph Tkacz, Yen Chung, Christopher S Ambrose, Joseph Spahn, Andrew W Lindsley

J Allergy Clin Immunol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Andrew W Lindsley

Adv Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic variation in disease burden among patients with severe persistent asthma in the United States.
Carlos A Camargo, Pallavi B Rane, Andrew F Beck, Yan Wang, Yen Chung, Andrew W Lindsley

Ann Allergy Asthma Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KMT2D regulates activation, localization, and integrin expression by T-cells.
Sarah J Potter, Li Zhang, Michael Kotliar, Yuehong Wu, Caitlin Schafer, Andrew W Lindsley

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At-home asthma mortality unchanged despite declining mortality in other settings: US death certificate data (2000-2019).
Karynsa Kilpatrick, Christopher S Ambrose, Andrew W Lindsley, John Oppenheimer

Ann Allergy Asthma Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
Ian D Pavord, Flavia C L Hoyte, Andrew W Lindsley, Christopher S Ambrose, Joseph D Spahn

Ann Allergy Asthma Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental cost burden among patients with severe uncontrolled asthma in the United States.
Autumn Burnette, Yan Wang, Pallavi B Rane, Yen Chung, Nicole Princic, Andrew W Lindsley

J Manag Care Spec Pharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.
Jonathan Corren, Christopher S Ambrose, Janet M Griffiths, Åsa Hellqvist, Andrew W Lindsley

Clin Exp Allergy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased nasal epithelial cell responsiveness to IL-17A in paediatric asthmatics with low blood neutrophil count, low traffic-related air pollution exposure and good asthma control.
Jaclyn W McAlees, Theresa Baker, Lauren Houshel, Christopher McKnight, Andrew Lindsley

Clin Exp Allergy· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.
Alec Wright, Arielle Hall, Tara Daly, Tatiana Fontelonga, Sarah Potter, Andrew Lindsley

FASEB J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophil responses during COVID-19 infections and coronavirus vaccination.
Andrew W Lindsley, Justin T Schwartz, Marc E Rothenberg

J Allergy Clin Immunol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical testing for COVID-19.
Stephanie Ward, Andrew Lindsley, Josh Courter, Amal Assa'ad

J Allergy Clin Immunol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"RE: Lin JL, et al. 'Immunologic assessment and KMT2D mutation detection in Kabuki syndrome.' Clin Genet. 2015;88(3):255-260".
Andrew W Lindsley

Clin Genet· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KMT2C/D COMPASS complex-associated diseases [KCOM-ADs]: an emerging class of congenital regulopathies.
William J Lavery, Artem Barski, Susan Wiley, Elizabeth K Schorry, Andrew W Lindsley

Clin Epigenetics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis